Medication choices in adult ADHD — what to consider first? (Rapid Review summary)

Population: Adult ADHD pharmacotherapy overview Type: Rapid Review (CADTH 2024 · NCBI Bookshelf) Nature: Summary/review — not an absolute guideline standard

Three-line summary

What: Adult ADHD medications are often framed as stimulant vs non-stimulant options.
Who: When misuse/diversion risk is present, contexts may favour considering non-stimulants; individual risk, comorbidity, and monitoring matter for prescribing decisions.
So what: Direct stimulant vs non-stimulant comparison evidence is limited in places. This source is a Rapid Review—not a substitute for clinical guidelines. Medication decisions require a qualified prescriber.

Keywords

rapid-review pharmacotherapy stimulant non-stimulant

Practical tips

Treat medication content as context for options, not instructions—dose changes belong with your prescriber.
A Rapid Review trades breadth/speed for depth; in-person assessment still drives individual fit.
Disclose misuse risk, cardiovascular issues, and comorbidities openly in medical visits.